{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:43Z","timestamp":1759333543942},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.det.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T04:27:53Z","timestamp":1316233673000},"page":"599-606","source":"Crossref","is-referenced-by-count":20,"title":["Evidence-Based Treatments in Pemphigus Vulgaris and Pemphigus Foliaceus"],"prefix":"10.1016","volume":"29","author":[{"given":"John W.","family":"Frew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2011.07.001_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006263.pub2","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","volume":"1","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.det.2011.07.001_bib2","first-page":"715","article-title":"Evidence-based treatment for a patient with oral pemphigus","volume":"5","author":"Li","year":"2005","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"key":"10.1016\/j.det.2011.07.001_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archdermatol.2007.14","article-title":"Treatment of pemphigus: the need for more evidence","volume":"144","author":"Martin","year":"2008","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2011.07.001_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-4362.1990.tb04765.x","article-title":"Pemphigus therapy with oral prednisolone regimens: a five year study","volume":"29","author":"Ratnam","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","article-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus vulgaris: results of a multicenter prospectively randomized study","volume":"3","author":"Rose","year":"2005","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.07.001_bib8","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A\u00a0comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib9","first-page":"689","article-title":"The actual management of pemphigus","volume":"145","author":"Daniel","year":"2010","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2011.07.001_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0378-6323.55390","article-title":"Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris","volume":"75","author":"Sethy","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.det.2011.07.001_bib11","first-page":"570","article-title":"Randomized control trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris","volume":"143","author":"Mentink","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-4362.1994.tb01003.x","article-title":"Treatment of oral pemphigus vulgaris","volume":"33","author":"Chrysomallis","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ioannides","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized placebo controlled trial of dapsone as a glucocorticoid sparing agent in maintenance phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.2009.09208.x","article-title":"The use of sulfasalazine and pentoxifylline (low cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study","volume":"161","author":"El-Darouti","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A\u00a0randomized double blind trial of intravenous immunoglobulin for\u00a0pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib20","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.124.11.1659","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-3083.2006.01873.x","article-title":"Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double blind, randomized controlled trial","volume":"21","author":"Tabrizi","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2011.07.001_bib22","first-page":"684","article-title":"Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double-blind placebo controlled clinical trial","volume":"9","author":"Iraji","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib23","first-page":"38","article-title":"The clinical and laboratory research for Chinese traditional medicine in the treatment of pemphigus","volume":"32","author":"Luo","year":"2003","journal-title":"J\u00a0Clin Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib24","first-page":"4","article-title":"Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus","volume":"17","author":"Pfutze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib25","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/jid.2009.72","article-title":"Reliability and convergent validity of two outcome instruments for pemphigus","volume":"129","author":"Rosenbach","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.07.001_bib26","series-title":"U.S. Preventive Services Task Force Ratings: grade definitions","author":"U.S. Preventive Services Task Force","year":"2000"},{"key":"10.1016\/j.det.2011.07.001_bib27","series-title":"Guide to clinical preventive services: report of the U.S. Preventive Services Task Force","author":"U.S. Preventive Services Task Force","year":"1989"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351100132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351100132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T02:20:16Z","timestamp":1543544416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351100132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S073386351100132X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2011.07.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}